| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AVEXIS INC COM | 1,035,657 | 37,795,000 | 22.81% | ||
| 2 | EDGE THERAPEUTICS INC | 1,933,582 | 19,549,000 | 11.80% | ||
| 3 | DBV Technologies | 373,617 | 17,436,000 | 10.52% | ||
| 4 | BIOCRYST PHARMACEUTICALS | 5,721,142 | 16,248,000 | 9.81% | ||
| 5 | Ascendis Pharma | 721,152 | 9,570,000 | 5.78% | ||
| 6 | REGENXBIO INC COM | 999,633 | 7,997,000 | 4.83% | ||
| 7 | HERON THERAPEUTICS INC | 405,901 | 7,327,000 | 4.42% | ||
| 8 | ALCOBRA LTD | 1,454,402 | 6,530,000 | 3.94% | ||
| 9 | CYTOMX THERAPEUTICS INC COM | 577,831 | 5,905,000 | 3.56% | ||
| 10 | AXOVANT SCIENCES LTD | 429,590 | 5,516,000 | 3.33% | ||
| 11 | AKARI THERAPEUTICS PLC | 369,490 | 4,984,000 | 3.01% | ||
| 12 | COHERUS BIOSCIENCES INC COM | 259,259 | 4,379,000 | 2.64% | ||
| 13 | Cynapsus Therapeutics Inc | 253,345 | 4,214,000 | 2.54% | ||
| 14 | BEIGENE LTD | 119,000 | 3,546,000 | 2.14% | ||
| 15 | ARCA biopharma Inc | 1,078,932 | 3,129,000 | 1.89% | ||
| 16 | GLOBAL BLOOD THERAPEUTICS IN COM | 170,312 | 2,825,000 | 1.71% | ||
| 17 | STEMLINE THERAPEUTICS INC | 315,980 | 2,139,000 | 1.29% | ||
| 18 | OCERA THERAPEUTICS INC | 948,372 | 1,802,000 | 1.09% | ||
| 19 | AEGLEA BIOTHERAPEUTICS INC COM | 350,133 | 1,527,000 | 0.92% | ||
| 20 | LIPOCINE INC NEW | 420,000 | 1,277,000 | 0.77% | ||
| 21 | ADVERUM BIOTECHNOLOGIES INC | 280,000 | 885,000 | 0.53% | ||
| 22 | ZAFGEN INC COM | 141,479 | 847,000 | 0.51% | ||
| 23 | ProNAi Therapeutics, Inc. | 130,798 | 260,000 | 0.16% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-019771, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
